A medical device company developing brain computer interface (BCI) products to help patients with neurological disorders regain the ability to walk, talk, see, hear, and feel again.

Treatment options to restore function for patients with neurological disorders including paralysis, ALS, and blindness are extremely limited. Blackrock’s BCI technology platform uses microelectrode arrays implanted in the brain to read and decode information directly from neurons, bypassing injured or diseased nerves and pathways to allow users to directly walk, talk, and devices such as computers, prostheses, and vehicles.  Similar electrodes can be used to encode and write information directly to neurons, allowing patients to regain sight, hearing, and physical sensation.  Overall, Blackrock’s breakthrough technology will transform the lives of individuals suffering from a wide range of neurological diseases, restoring their independence and ability to interact more naturally with the world around them.